Mallinckrodt plc

$0.34-14.97%($-0.06)
TickerSpark Score
48/100
Weak
100
Valuation
40
Profitability
10
Growth
60
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MNK research report →

52-Week Range0% of range
Low $0.30
Current $0.34
High $16.00

Companywww.mallinckrodt.com

Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes; and gastrointestinal products.

CEO
Sigurdur Oli Olafsson
IPO
2022
Employees
2,673
HQ
Dublin, IE

Price Chart

-99.35% · this period
$15.49$7.79$0.09Oct 28Apr 11Sep 19

Valuation

Market Cap
$4.52M
P/E
-0.02
P/S
0.00
P/B
0.01
EV/EBITDA
-3.50
Div Yield
0.00%

Profitability

Gross Margin
42.36%
Op Margin
-38.28%
Net Margin
-38.90%
ROE
-26.10%
ROIC
-11.04%

Growth & Income

Revenue
$1.43B · -27.74%
Net Income
$-489,500,000 · -202.43%
EPS
$-17.48 · -172.05%
Op Income
$-457,500,000
FCF YoY
57.05%

Performance & Tape

52W High
$16.00
52W Low
$0.30
50D MA
$1.02
200D MA
$5.68
Beta
0.00
Avg Volume
3.71M

Get TickerSpark's AI analysis on MNK

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Dec 5, 23GOLDENTREE ASSET MANAGEMENT LPbuy75,000
Dec 4, 23GOLDENTREE ASSET MANAGEMENT LPother0
Nov 14, 23Zinman Jonother0
Nov 14, 23Stetson David J.other0
Nov 14, 23Bracebridge Capital, LLCother1,093,857
Nov 14, 23Bracebridge Capital, LLCother2,033,257
Nov 14, 23Harrold Kassiesell32,000
Nov 14, 23Olafsson Sigurdur Osell189,863
Nov 14, 23Olafsson Sigurdur Osell672,948
Nov 14, 23Nielsen Henriettesell62,288

Our MNK Coverage

We haven't published any research on MNK yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate MNK Report →

Similar Companies